Prosecution Insights
Last updated: July 17, 2026

Inskeep Intellectual Property Group, Inc.

35 pending office actions • 15 clients • 33 examiners • 14 art units • 0 of 35 (0%) have an AI response strategy ready • 45 patents granted in the last 365 days

Quality Metrics (n=3826 apps, methodology: how we score firms)

82.0%
Allowance Rate
n=3826
+0.52σ
Allowance Rate (norm)
n=3826
3.7
OAs to Allowance
n=1984
-0.06σ
OAs to Allow (norm)
n=1984
1094 days
Time to Allowance
n=1984
+10.0pp
Interview Lift
n=3826
29.6%
RCE Rate
n=3826
1.2%
Appeal Rate
n=3826

Rejection Performance (% of received rejections ultimately overcome)

78.6%
§101 Overcome
n=42
84.0%
§102 Overcome
n=325
81.7%
§103 Overcome
n=1255
90.2%
§112 Overcome
n=315

Specialization & Scale

A61B, A61F, A61M
Top CPC Subclasses
25%
Top-3 CPC Share
n=3826
2
Practitioners
n=3826
1913.0
Apps / Practitioner
n=3826

Portfolio Summary

35
Total Pending OAs
24
Non-Final OAs
10
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
3
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (3)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
29
Medium (83%)
5
Easy (14%)
1
Unknown (3%)

Rejection Statute Mix

BucketCases
§103 only26 (74%)
§102 only2 (6%)
§112 only1 (3%)
Double-patenting only4 (11%)
Double-patenting + other1 (3%)
No statute on record1 (3%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
3% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
3
Semiconductors
9% of docket
26
Mechanical / Eng
74% of docket
5
Business / Other
14% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

350 h
Manual time on pending OAs
70 h
Time saved (low, 20%)
122 h
Time saved (mid, 35%)
3.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YABUT, DIANE D 2 62.4% +27.9%
BLAISE, BRADFORD CHRISTOPHER 2 60.1% +32.3%
HEREDIA OCASIO, ARLENE J 1 75.4% +3.9%
WOODALL, NICHOLAS W 1 82.1% +13.1%
GHAND, JENNIFER LEIGH-STEWAR 1 60.2% +27.9%
CHRISTIANSON, SKYLAR LINDSEY 1 58.7% +28.8%
KOWALKOWSKI, FIONA MARGARET 1 100.0% +0.0%
CHOUDHURY, MUSTAK 1 84.6% +22.1%
HOLWERDA, KATHLEEN SONNETT 1 68.6% +17.4%
SHI, KATHERINE MENGLIN 1 78.5% +21.9%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19203989 Spinal Disc Implant And Device And Method For Percutaneous Delivery Of The Spinal Disc Implant WOODALL, NICHOLAS W
18893680 INDIUM TIN OXIDE REFLECTION CONTROL CHOUDHURY, MUSTAK

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18795018 Method And Apparatus For Stent Delivery SHI, KATHERINE MENGLIN 15d
18147587 Apparatus And Method For Controlling Laser Thermotherapy BLAISE, BRADFORD CHRISTOPHER 26d
19203989 Spinal Disc Implant And Device And Method For Percutaneous Delivery Of The Spinal Disc Implant WOODALL, NICHOLAS W
19174781 Asymmetric Occluder Device YABUT, DIANE D
19045628 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE GHAND, JENNIFER LEIGH-STEWAR
18894729 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE CHRISTIANSON, SKYLAR LINDSEY
18893680 INDIUM TIN OXIDE REFLECTION CONTROL CHOUDHURY, MUSTAK
18887772 IMPLANT DELIVERY SYSTEM HOLWERDA, KATHLEEN SONNETT

Client Portfolio (15 clients)

Top Art Units

Art UnitApps
37719
37945
37922
28722
37962
37812
28521
37831
37521
37991

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19333294 DEVELOPING CARTRIDGE Zhuhai Dinghui Technology Co., Ltd. HEREDIA OCASIO, ARLENE J 2852 §102 Non-Final OA Pending Sep 18, 2025
19203989 Spinal Disc Implant And Device And Method For Percutaneous Delivery Of The Spinal Disc Implant Percheron Spine, LLC WOODALL, NICHOLAS W DP Non-Final OA Pending May 09, 2025
19174781 Asymmetric Occluder Device Occlutech GmbH YABUT, DIANE D DP Non-Final OA Pending Apr 09, 2025
19045628 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION GHAND, JENNIFER LEIGH-STEWAR DP Non-Final OA Pending Feb 05, 2025
18894729 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION CHRISTIANSON, SKYLAR LINDSEY 3792 §103 Non-Final OA Pending Sep 24, 2024
18894577 MEDICAL DEVICE FOR TREATING DECOMPENSATED HEART FAILURE BOSTON SCIENTIFIC CORPORATION KOWALKOWSKI, FIONA MARGARET 3792 Non-Final OA Pending Sep 24, 2024
18893680 INDIUM TIN OXIDE REFLECTION CONTROL Hoya Optical Labs Of America, Inc. CHOUDHURY, MUSTAK §103 Non-Final OA Pending Sep 23, 2024
18887772 IMPLANT DELIVERY SYSTEM Microvention, Inc. HOLWERDA, KATHLEEN SONNETT 3771 §103 Non-Final OA Pending Sep 17, 2024
18795018 Method And Apparatus For Stent Delivery Microvention, Inc. SHI, KATHERINE MENGLIN 3771 §102 Non-Final OA 15d Pending Aug 05, 2024
18791312 OPHTHALMIC LENS WITH MICROLENSES FOR THERAPEUTIC MANAGEMENT Hoya Optical Labs Of America, Inc. MOSER, SETH DAVID 2872 §103 Non-Final OA Pending Jul 31, 2024
18727061 METHODS AND DEVICES FOR REMOVING HEART VALVE THERAPY Amx Technologies, LLC FOWLER, DANIEL WAYNE 3794 §103 Final Rejection Pending Jul 05, 2024
18658423 Occlusion Systems Terumo Corporation LE, KHOA TAN 3771 §103 Final Rejection Pending May 08, 2024
18648134 Light Emitting Opthalmic Lens Hoya Optical Labs Of America, Inc. SAHAND, SANA 3796 §103 Final Rejection Pending Apr 26, 2024
18699153 WIRE GRID POLARIZER REFLECTION CONTROL WITH COLORED FILMS Hoya Optical Labs Of America, Inc. DABBI, JYOTSNA V 2872 §103 Non-Final OA Pending Apr 05, 2024
18692118 ASPIRATION THROMBECTOMY SYSTEM Microvention, Inc. LEVY, BRANDON WILLIAM 3781 §103 Final Rejection 83d Pending Mar 14, 2024
18292285 OBSTRUCTION REMOVAL SYSTEM Microvention, Inc. LABRANCHE, BROOKE N 3771 §103 Non-Final OA Pending Jan 25, 2024
18576356 STRETCH RESISTANT EMBOLIC COIL Microvention, Inc. NEMER, OSAMA MOHAMMAD 3771 §103 Non-Final OA 41d Pending Jan 03, 2024
18398003 Left Atrial Appendage Stasis Reduction Nidus Biomedical, LLC WIEST, PHILIP R 3781 DP Non-Final OA Pending Dec 27, 2023
18390689 Method And Apparatus For Minimizing Excess Drug Delivery Terumo Corporation HALL, DEANNA K 3783 §103 Non-Final OA Pending Dec 20, 2023
18390337 Battery Extinguishing Device Firekim Energy Solution Co., Ltd. SUTHERLAND, STEVEN M 3752 §103 Non-Final OA 17d overdue Pending Dec 20, 2023
18537718 Conductive Circuit Caldera Medical, Inc. FEDORKY, MEGAN TAYLOR 3796 §103 Non-Final OA Pending Dec 12, 2023
18566458 REMOVAL OF HEAT STABLE AMINE SALTS FROM LIQUID STREAMS AND RELATED PROCESSES Electrosep Inc. CONTRERAS, CIEL P §103 Non-Final OA Pending Dec 01, 2023
18503116 FLOW REGULATING DEVICE IN THE HEART Occlutech GmbH DEAK, LESLIE R 3799 DPOther Non-Final OA Pending Nov 06, 2023
18496259 Vascular Occlusion Terumo Corporation DORNBUSCH, DIANNE 3771 §103 Non-Final OA 21d Pending Oct 27, 2023
18338587 Stent Delivery System And Method Microvention, Inc. RESTAINO, ANDREW PETER 3771 §103 Final Rejection Pending Jun 21, 2023
18303469 Waterproof Shoe And Manufacturing Method For The Waterproof Shoe Foshan Chenxi Textile Co., Ltd. COLLIER, JAMESON D 3732 §103 Non-Final OA 134d overdue Pending Apr 19, 2023
18044761 Method And Device For Removing Heart Valve Therapy Amx Technologies, LLC BOCK, ABIGAIL MARIE 3794 §103 Non-Final OA 9d overdue Pending Mar 09, 2023
18147587 Apparatus And Method For Controlling Laser Thermotherapy Clinical Laserthermia Systems AB BLAISE, BRADFORD CHRISTOPHER 3794 §112 Final Rejection 26d Pending Dec 28, 2022
18062491 Stent And Stent Connection Interface Microvention, Inc. GANESAN, SUBA 3774 §103 Final Rejection 45d overdue Pending Dec 06, 2022
17815549 Apparatus And Method For Contacting Blood With Ozone Sangair AB MELLON, DAVID C 1779 §103 Final Rejection 321d overdue Pending Jul 27, 2022
17810241 Midline Marker For Sling Implant Caldera Medical, Inc. PENG, BO JOSEPH 3797 §103 Non-Final OA 33d Pending Jun 30, 2022
17805639 Access Device And System For A Heart Including A Cardiac Assist Unit Syntach AG YABUT, DIANE D 3771 §103 Non-Final OA Pending Jun 06, 2022
17499711 Pulmonary Embolism Removal System Terumo Corporation DUBOSE, LAUREN 3771 §103 Final Rejection 112d overdue Pending Oct 12, 2021
16470129 Apparatus And Method For Controlling Laser Thermotherapy Clinical Laserthermia Systems AB BLAISE, BRADFORD CHRISTOPHER 3794 §103 Final Rejection Pending Jun 14, 2019
15619110 Apparatus And Methods For Determining A Property Of A Tissue Clinical Laserthermia Systems AB SMITH, KAITLYN ELIZABETH 3794 §103 Non-Final OA 60d overdue Pending Jun 09, 2017

Managing Inskeep Intellectual Property Group, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month